Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -31.1% | +23.0% | 1 / 3 | +3.3% | +0.35 pp | -16.43 pp | +11.8% | 0.77 | 5.68 | 106 | +3,3% | 43,6 | −26,2% | 5.68 | 6.23 | −8,9% |
| Pts | 0 | 0 | 4 | 0 | 8 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 55.000 (close price on 2026-10-15)EPS (TTM): 9.686
Financial charts
1.Revenue & growth
VND bn106Q2/26
1.Revenue & growth
VND bn106Q2/26
2.Profit & growth
VND bn33,3Q2/26
3.Profit mix (Penman)
VND bn142Q2/26
4.Margins & cost structure
%53.0%Q2/26
5.Returns & cash cycle
% · days10.0%Q2/26
6.Earnings quality & cash
VND bn175Q2/26
7.Asset structure
VND bn2.235Q2/26
8.Funding & debt health
VND bn · times2.235Q2/26
9.Revenue backlog
VND bn200Q2/26
10.Valuation
times · %5,7×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %3.335Q2/26
Adjusted EPS growth, latest quarter
-31.1%
Average adjusted EPS growth, 3 quarters
23.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26